Search - tctmd.com

Displaying 1 - 20 of 2675

Sort: Relevancy | Date

Presentation

Individual Operator Experience and Outcomes in TAVR

December 12, 2018

Presentation

Association of RAS Treatment With Mortality and Heart Failure Readmission in TAVR Patients

December 12, 2018

Presentation

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

December 10, 2018

Presentation

Sex Differences in Quality Indicator Attainmentfor MI: Nationwide Cohort Study

November 29, 2018

Presentation

Predictors and Outcomes of Staged vs One-Time Revascularization in Multivessel CAD

November 20, 2018

Presentation TCT Abstracts Posters 2018

Impact of contrast injection on intracoronary pressure during optical coherence tomography imaging

Presenter: Kunihiro Shimamura

November 16, 2018

Presentation AHA 2018

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L Bhatt

November 16, 2018

Presentation AHA 2018

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

Presenter: Heribert Schunkert

November 14, 2018

Presentation AHA 2018

REGROUP Trial: A Prospective, Randomized TRial Comparing Endoscopic vs. Open Vein Grafts in CABG Surgery

Presenter: Marco A. Zenati

November 13, 2018

Presentation AHA 2018

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

Presenter: Eric J Velazquez

November 12, 2018

Alert-Based Computerized Decision Support to Increase Anticoagulation Prescription Prevents Stroke and Myocardial Infarction in High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presentation AHA 2018

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Presenter: Gregory Piazza

November 11, 2018

Presentation AHA 2018

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

Presenter: Sotirios Tsimikas

November 11, 2018

Presentation AHA 2018

DECLARE - TIMI 58

Presenter: Stephen Wiviott

November 11, 2018

Presentation VIVA 2018

LUTONIX BTK Trial

Presenter: Jihad Mustapha

November 09, 2018

Presentation VIVA 2018

TOBA II 12-Month Data

Presenter: William Gray

November 09, 2018

Presentation VIVA 2018

1-Year Outcomes for Eluvia in Long Lesions

Presenter: William A. Gray

November 09, 2018

Presentation

Neurological Complications After TAVR vs SAVRin Intermediate-Risk Patients

October 22, 2018

Presentation

Complete vs Culprit-Only Lesion Intervention in Patients With ACS

October 16, 2018

Presentation CDM 2018

With the Explosion in Growth of HF, What is the Role of an Outpatient Oriented HF Clinic in Your Practice?

Presenter: Nancy K. Sweitzer

October 12, 2018

Presentation CDM 2018

What About PFO Closure for Migraines, is There Convincing Evidence to Treat?

Presenter: Robert J. Sommer

October 12, 2018

Advertisement

Individual Operator Experience and Outcomes in TAVR

Association of RAS Treatment With Mortality and Heart Failure Readmission in TAVR Patients

SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in FREEDOM

Sex Differences in Quality Indicator Attainmentfor MI: Nationwide Cohort Study

Predictors and Outcomes of Staged vs One-Time Revascularization in Multivessel CAD

Impact of contrast injection on intracoronary pressure during optical coherence tomography imaging

REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Ticagrelor vs Aspirin in Patients undergoing Coronary-Artery Bypass Grafting

REGROUP Trial: A Prospective, Randomized TRial Comparing Endoscopic vs. Open Vein Grafts in CABG Surgery

PIONEER Trial: Angiotensin Receptor-NeprilysinInhibition in Patients Hospitalized With Acute Decompensated Heart Failure

High-Risk Hospitalized Patients with Atrial Fibrillation: A Randomized, Controlled Trial (AF-ALERT)

Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial

DECLARE - TIMI 58

LUTONIX BTK Trial

TOBA II 12-Month Data

1-Year Outcomes for Eluvia in Long Lesions

Neurological Complications After TAVR vs SAVRin Intermediate-Risk Patients

Complete vs Culprit-Only Lesion Intervention in Patients With ACS

With the Explosion in Growth of HF, What is the Role of an Outpatient Oriented HF Clinic in Your Practice?

What About PFO Closure for Migraines, is There Convincing Evidence to Treat?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content